Phil Kerpen, Founder and President of American Commitment, discusses how drug price controls would hurt seniors as they would reduce access to and undermine research and development in life-saving biopharmaceuticals, and why the Build Back Better Act under consideration in Congress is riddled with other disastrous provisions.
